<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03047304</url>
  </required_header>
  <id_info>
    <org_study_id>0531-15-RMB</org_study_id>
    <nct_id>NCT03047304</nct_id>
  </id_info>
  <brief_title>Magnesium Effect on Embryonal PR Interval</brief_title>
  <official_title>Magnesium Effect on Embryonal PR Interval</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Magnesium is a known treatment for neuroprotection in preterm labor before 32 week of
      gestation. High concentration of Magnesium in the blood stream known as cause of conduction
      abnormalities and ECG changes such us prolonged QT, QRS and PR in about. The goal of our work
      is to evaluate the PR intervals in embryos after maternal treatment with magnesium during
      preterm labor.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We will recruit 25 woman with threaten preterm labor, magnesium blood level and PR interval
      will be evaluated before magnesium loading dose (4gr) and 20 minutes after the loading dose.

      PR interval will be evaluated by Mitral-Aorta Doppler.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 14, 2017</start_date>
  <completion_date type="Anticipated">March 10, 2018</completion_date>
  <primary_completion_date type="Anticipated">February 10, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prolonged PR interval</measure>
    <time_frame>20 min after magnesium treatment</time_frame>
    <description>PR will be measured by Mitral-aorta doppler</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Preterm Labor</condition>
  <arm_group>
    <arm_group_label>Women in risk for preterm labor</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Women in risk for preterm labor treated with magnesium.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Trans abdominal sonography</intervention_name>
    <description>Trans abdominal sonography in order to measure fetal PR interval.</description>
    <arm_group_label>Women in risk for preterm labor</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women at risk for preterm labor before 32 week of gestation

        Exclusion Criteria:

          -  Fetal malformations

          -  Maternal Lupus

          -  Fetal conduction abnormalities
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ola Gutzeit, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Principal Investigator</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ola Gutzeit, MD</last_name>
    <phone>972543088220</phone>
    <email>ola.gutzeit@gmail.com</email>
  </overall_contact>
  <reference>
    <citation>Gums JG. Clinical significance of magnesium: a review. Drug Intell Clin Pharm. 1987 Mar;21(3):240-6. Review.</citation>
    <PMID>3552543</PMID>
  </reference>
  <reference>
    <citation>Agus ZS, Morad M. Modulation of cardiac ion channels by magnesium. Annu Rev Physiol. 1991;53:299-307. Review.</citation>
    <PMID>1710436</PMID>
  </reference>
  <reference>
    <citation>Laurant P, Touyz RM. Physiological and pathophysiological role of magnesium in the cardiovascular system: implications in hypertension. J Hypertens. 2000 Sep;18(9):1177-91. Review.</citation>
    <PMID>10994748</PMID>
  </reference>
  <reference>
    <citation>Glickstein JS, Buyon J, Friedman D. Pulsed Doppler echocardiographic assessment of the fetal PR interval. Am J Cardiol. 2000 Jul 15;86(2):236-9.</citation>
    <PMID>10913494</PMID>
  </reference>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 6, 2017</study_first_submitted>
  <study_first_submitted_qc>February 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2017</study_first_posted>
  <last_update_submitted>February 13, 2017</last_update_submitted>
  <last_update_submitted_qc>February 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>Ola Gutzeit MD</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obstetric Labor, Premature</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

